Showing results (361-370 of 2,192) with videos related to
Sort By:
Pageof 220
European Journal of Clinical Pharmacology|January 1, 1981
Antihypertensive and hormonal effects of single oral doses of captopril and nifedipine in essential hypertensionM E Soto, M Thibonnier, O Sire, et al.Annales D'Endocrinologie|September 1, 1980
[Sensitive radioimmunoassay for plasma arginine vasopressin (author's transl)]M Thibonnier, M E Soto, J Marchetti, et al.Hypertension (Dallas, Tex. : 1979)|November 1, 1985
Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNAN Nakamura, F Soubrier, J Menard, et al.Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|October 24, 2001
Maturation-dependent neointima formation in fowl aortaH Nishimura, Z Xi, L Zhang, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1987
[Predictive factors of resistance to antihypertensive treatment]G Chatellier, J Ménard, C Devries, et al.International Journal of Peptide and Protein Research|December 1, 1986
Solution synthesis of antigenic and inhibiting peptides of the human renin prosegment-1. [Tyr47, Nle53] preprorenin-(47-60) peptide methyl esterJ A Fehrentz, R Seyer, A Heitz, et al.International Journal of Peptide and Protein Research|December 1, 1986
Solution synthesis of antigenic and inhibiting peptides of the human renin prosegment-2. [Tyr40] preprorenin-(40-50) peptide methyl esterJ A Fehrentz, R Seyer, A Heitz, et al.Biochemistry|November 24, 1981
Rat angiotensinogen and des(angiotensin I)angiotensinogen: purification, characterization, and partial sequencingJ Bouhnik, E Clauser, D Strosberg, et al.Hormone Research|January 1, 1990
Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosisP F Plouin, P Cudek, J F Arnal, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2000
Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassayC Parnot, S Bardin, S Miserey-Lenkei, et al.Pageof 220